Cyanodothiepin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Cyanodothiepin
Cyanodothiepin.svg
Systematic (IUPAC) name
11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]thiepine-2-carbonitrile
Clinical data
Legal status ?
Identifiers
CAS number 90667-37-1
ATC code None
ChemSpider 30780728
Chemical data
Formula C20H20N2S 
Mol. mass 320.45 g/mol

Cyanodothiepin (BTS-56,424) is a drug of the tricyclic antidepressant (TCA) family which is a potent and highly selective (over norepinephrine and dopamine uptake) inhibitor of the reuptake of serotonin.[1][2][3] It also has moderate affinity for the mACh receptors and weak/negligible affinity for the α1-adrenergic, 5-HT2A, D1, and D2 receptors;[1][2][3] the H1 receptor has not been assayed,[3] but cyanodothiepin is less sedating than the related drug cianopramine, suggesting its antihistamine activity is not as pronounced as other TCAs.[1][3] Cyanodothiepin is active in the forced swimming test (FST), inferring that it may possess antidepressant properties in humans. However, it is only weakly active compared to cianopramine and imipramine in monoamine depletion-based tests of antidepressant potential.[1]

See also[edit]

References[edit]

  1. ^ a b c d Luscombe, G. P.; Buckett, W. R. (1993). "Pharmacology of Cyanodothiepin (BTS 56 424), a Selective 5-Hydroxytryptamine Reuptake Inhibitor". Drug Development Research 29 (3): 235–248. doi:10.1002/ddr.430290311. 
  2. ^ a b Jucker , E. (2000). Progress in Drug Research. Birkhäuser. pp. 79–80. ISBN 978-3-7643-6113-6. Retrieved 2011-11-25. 
  3. ^ a b c d Olivier, B.; van Wijngaarden, I.; Soudijn, W. (1997). Serotonin Receptors and their Ligands. Elsevier. p. 332. ISBN 978-0-444-82041-9. Retrieved 2011-11-25.